OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights
Wagdy M. Eldehna, Haytham O. Tawfik, Maha-Hamadien Abdulla, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107804-107804
Closed Access | Times Cited: 6
Wagdy M. Eldehna, Haytham O. Tawfik, Maha-Hamadien Abdulla, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107804-107804
Closed Access | Times Cited: 6
Showing 6 citing articles:
Development of 1,2,3-triazole hybrids as multi-faced anticancer agents co-targeting EGFR/mTOR pathway and tubulin depolymerization
Mennatallah A. Shaheen, Khaled M. Darwish, Safaa M. Kishk, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108153-108153
Closed Access | Times Cited: 3
Mennatallah A. Shaheen, Khaled M. Darwish, Safaa M. Kishk, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108153-108153
Closed Access | Times Cited: 3
Design, synthesis, and molecular dynamics-driven evaluation of quinoline-sulfonamide derivatives as potent and selective EGFR inhibitors with promising anti-cancer efficacy and safety profiles
Mahmoud S. Elkotamy, Mohamed K. Elgohary, Islam A. Elkelesh, et al.
Bioorganic Chemistry (2025), pp. 108247-108247
Closed Access | Times Cited: 2
Mahmoud S. Elkotamy, Mohamed K. Elgohary, Islam A. Elkelesh, et al.
Bioorganic Chemistry (2025), pp. 108247-108247
Closed Access | Times Cited: 2
Design, synthesis and biological evaluation of pyrazolo[3,4- b ]pyridine derivatives as dual CDK2/PIM1 inhibitors with potent anti-cancer activity and selectivity
Mahmoud S. Elkotamy, Mohamed K. Elgohary, Mahmoud Abdelrahman Alkabbani, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-25
Closed Access | Times Cited: 2
Mahmoud S. Elkotamy, Mohamed K. Elgohary, Mahmoud Abdelrahman Alkabbani, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-25
Closed Access | Times Cited: 2
Discovery of 1-phenyl-1,2,3-triazole ureas as dual VEGFR-2/JNK-1 type II kinase inhibitors targeting pancreatic cancer
Wagdy M. Eldehna, Eslam Roshdy, Maha-Hamadien Abdulla, et al.
International Journal of Biological Macromolecules (2025), pp. 142372-142372
Closed Access | Times Cited: 1
Wagdy M. Eldehna, Eslam Roshdy, Maha-Hamadien Abdulla, et al.
International Journal of Biological Macromolecules (2025), pp. 142372-142372
Closed Access | Times Cited: 1
Molecular docking, DFT and antiproliferative properties of 4‐(3,4‐dimethoxyphenyl)−3‐(4‐methoxyphenyl)−1‐phenyl‐1H‐pyrazolo[3,4‐b]pyridine as potent anticancer agent with CDK2 and PIM1 inhibition potency
Faizah A. Binjubair, Basma S. Almansour, Noha I. Ziedan, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access | Times Cited: 5
Faizah A. Binjubair, Basma S. Almansour, Noha I. Ziedan, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access | Times Cited: 5
Development of indole hybrids for potential lung cancer treatment-part I: nitrogen-containing six-membered aromatic heterocycles
Shijia Zhao, Zhi Xu
Future Medicinal Chemistry (2025), pp. 1-17
Closed Access
Shijia Zhao, Zhi Xu
Future Medicinal Chemistry (2025), pp. 1-17
Closed Access
